Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-02-18

Clinical Trial Update: Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing triple target stimulation (AM-MF, EMG-triggered stimulation) with EMG-biofeedback for fecal incontinence has completed enrollme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Giessen | Conditions: Fecal Incontinence | Phase 3 | Status: COMPLETED